Safety and Efficacy of Short-Term Steroid in Patients with Hepatocellular Carcinoma undergoing Transarterial Chemo Embolization - A Randomized, Double-Blind, Placebo Controlled Trial
Not Applicable
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- JPRN-UMIN000004317
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)Second primary malignancy 2)Active infection 3)Extrahepatic metastasis 4)Epatoencepharopathy 5)Uncontrolable Pleural effusion and ascitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of patients with complete response, defined as no fever, no nausea, no vomiting, and no anorexia, during 120 hours after TACE.
- Secondary Outcome Measures
Name Time Method